GE to invest $1 billion in cancer research

September 15, 2011

US industrial conglomerate General Electric said on Thursday that it would invest $1 billion in cancer research over the next five years.

GE chief executive Jeff Immelt and several venture capital partners launched the initiative, which will be aimed at improving for , the company said in a statement.

The investment will go toward research and development into technologies and solutions for cancer detection and treatment, beginning with breast cancer, GE said.

GE and its partners also announced a $100 million "global open innovation challenge" to provide grants to researchers who develop promising early-detection techniques.

The contest will focus on triple negative breast cancer, a particularly aggressive kind of breast cancer which is less responsive to standard treatments than other forms of the disease.

The winners will be announced in the first quarter of 2012 after selection by a jury that includes top cancer scientists as well as representatives of GE and its financial partners, the company said.

"We envision a day when cancer is no longer a ," Immelt said in the statement.

"When you add our cutting edge technologies to the innovative ideas of our new partners, it's a powerful formula for tackling cancer and helping doctors and researchers improve care."

GE's partners in the initiative include top venture-capital firm Kleiner Perkins Caufield & Byers as well as Venrock, Mohr Davidow and MPM Capital.

Explore further: Men with breast cancer face high risk of second cancer

Related Stories

GE to open advanced tech center in Michigan

June 26, 2009

General Electric announced plans Friday to open an "advanced manufacturing technology and software center" in Michigan that could create more than 1,100 job in the coming years.

Heart disease beats breast cancer as the biggest killer

June 19, 2011

Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

TechCrunch founder starts venture capital fund

September 2, 2011

(AP) -- Michael Arrington, founder of popular tech blog TechCrunch, is starting a venture capital firm with an initial $20 million to invest in the same kinds of startups that TechCrunch often covers.

Recommended for you

Oxygen can impair cancer immunotherapy in mice

August 25, 2016

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers. This mechanism involves oxygen inhibition of the anticancer ...

Stem cell propagation fuels cancer risk in different organs

August 25, 2016

The idea that stem cells - special cells that divide to repair and generate tissues - might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.